| ²é¿´: 1357 | »Ø¸´: 5 | |||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õß²¤ÂÜÃÛ½«ÔùËÍÄú 300 ¸ö½ð±Ò | |||
²¤ÂÜÃÛľ³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÎÄÕÂͶ¸åÒ»Éó¸øµÄ»Ø¸´ºÜ¾À½á£¬ÓоÑéµÄºÍÓ¢ÓïºÃµÄÄܰïæ»Ø¸´Âð£¿
|
||
|
ÎÒµÄÎÄÕÂÖ÷ÒªÑо¿µÄÊÇÒ»ÖÖÒ©Îï΢Á£µÄÖÆ±¸£¬ÊµÑé±íÕ÷Ò²Ö»ÊÇÉæ¼°ÌåÍâʵÑ飬ÏÖÔÚÓÐÒ»¸öÉó¸åÈ˸øµÄ»Ø¸´ËµÈç¹ûÄܹ»×öһЩÌåÄÚÊÍ·ÅʵÑéËû»á·Ç³£¸ßÐË¡£ µ«Êµ¼ÊÉÏÌåÍâºÍÌåÄÚÑо¿¿ÉÒÔ˵ÔÚÒ½Ò©ÐÐÒµ¾Í²»ÊÇÒ»¸öרҵÁìÓò£¬¶øÇÒ×öÌåÄÚʵÑéÖÜÆÚºÜ³¤£¬ÊµÑéÊÒҲûÕâ¸öÌõ¼þ¡£ÏÖÔÚ²»×¼±¸²¹ÊµÑéÁË£¬²»ÖªµÀÈçºÎίÍñµÄ»Ø¸´Ëû¡£¼ÓÉϽñÄê¹ýÄêÌØ±ð棬ÓоÑéµÄ£¬ÄܰïÎһظ´ÏÂÉó¸åÈ˵ÄÒâ¼ûÂð£¿ÔÚ´ËÏÈÍò·Ö¸ÐлÁË¡£ÒªÇ󻨏´ÓïÑÔÇ«Ð飬ÀíÓɳä·Ö£¬Ó¢ÓïÓïÑÔ¹ý¹Ø£¬Ð»Ð»Äú£¡ »Ø¸´µÄʱºò¿ÉÒÔ˵ vivo tests ÊÇÏÂÒ»²½¹¤×÷£¬¼ÌÐøÕ¹ÍûµÄÄÚÈÝ¡£ ÏÂÃæÊÇÉó¸åÈ˵Ļظ´£¬ÔÙ´ÎÍò·Ö¸Ðл! Reviewer #1: It is an interesting and well written manuscript with good results, suitable for publication in SUPFLU. Particularly, solubility data and dissolution rate values may constitute valuable data for practical applications in medicinal field. In this regard I would be glad if authors could comment on in vivo or in vivo tests of raw and micronized drug. |
» ²ÂÄãϲ»¶
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ18È˻ظ´
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ3È˻ظ´
½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û
ÒѾÓÐ21È˻ظ´
¹À¼ÆÊÇÖÜËÄ
ÒѾÓÐ4È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ9È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ18È˻ظ´
½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã
ÒѾÓÐ15È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ7È˻ظ´
ÅóÓÑȦ¿´µ½µÄ
ÒѾÓÐ9È˻ظ´
ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡
ÒѾÓÐ16È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
ÖÜÓׯ½
гæ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 315.3
- ºì»¨: 3
- Ìû×Ó: 95
- ÔÚÏß: 6.3Сʱ
- ³æºÅ: 4386025
- ×¢²á: 2016-01-28
- רҵ: ÓлúºÏ³É
|
We appreciate the positive comments and we also concur with reviewer 1 regarding the utility of in vivo data, which is in fact the focus of our ongoing research and we plan to pulished our results in due course in the future. Please also note that the in vivo studies are time consuming and requires substantial efforts. We wish to publish our current in vitro results as a standalone report so as to timely commubicate our findings with colleagues in [this] area and will definitely follow up on the in vivo questions. ´óÖÂÕâô¸öÒâ˼°É£¬ËæÊÖºú³¶µÄ ·¢×ÔСľ³æIOS¿Í»§¶Ë |
2Â¥2016-01-30 21:46:17
Äϼ«µÄÎʺò
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 13 (СѧÉú)
- ½ð±Ò: 1326.6
- É¢½ð: 61
- ºì»¨: 6
- Ìû×Ó: 1039
- ÔÚÏß: 80.8Сʱ
- ³æºÅ: 3063630
- ×¢²á: 2014-03-17
- ÐÔ±ð: GG
- רҵ: µçÁ¦µç×Óѧ

3Â¥2016-01-31 09:55:20
esse1990
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 554.1
- ºì»¨: 1
- Ìû×Ó: 146
- ÔÚÏß: 82.3Сʱ
- ³æºÅ: 3848966
- ×¢²á: 2015-05-04
- רҵ: ÎïÁ÷Ó빩ӦÁ´¹ÜÀí
4Â¥2016-01-31 10:56:04
bpguxin
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 3190.8
- ºì»¨: 2
- Ìû×Ó: 30
- ÔÚÏß: 323.6Сʱ
- ³æºÅ: 1867441
- ×¢²á: 2012-06-23
- רҵ: »·¾³µØÇò»¯Ñ§
|
Éó¸åÈËûÓÐÈÃÄã²¹Êý¾Ý°¡¡£ÊÇÈÃÄãÆÀ¹ÀÒ»ÏÂÌåÄÚµÄЧ¹û¡£ÎÒÏëÕâÊǺܺõĽ¨Ò飬ÓÐÖúÓÚÌáÉýÎÄÕµÄbroad impact¡£ ·¢×ÔСľ³æIOS¿Í»§¶Ë |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
5Â¥2016-01-31 22:17:56
²¤ÂÜÃÛ
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1062
- ºì»¨: 4
- Ìû×Ó: 19
- ÔÚÏß: 78.7Сʱ
- ³æºÅ: 842206
- ×¢²á: 2009-09-06
- רҵ: Ò©¼Áѧ
Ëͺ컨һ¶ä |
ÄãºÃ£¬·Ç³£¸ÐлÄãµÄ»Ø¸´£¬Õâ¸öcomment onÎÒÒ²¾À½áÁ˰ëÌ죬µ«Äã˵µÄÆÀ¹ÀÊÇʲôÒâË¼ÄØ£¬¾ÍÊÇ×öÒ»ÏÂÔ¤²âÂð£¿ÎÒ¾õµÃûÓÐ×öÒ»µãÏà¹ØÊµÑ飬ûÓÐÊý¾Ý£¬ÎÞ·¨Ô¤²â°¡£¿ ·¢×ÔСľ³æIOS¿Í»§¶Ë |
6Â¥2016-02-01 10:41:06









»Ø¸´´ËÂ¥
20